Clinical Trials in Baltimore

Showing 7521-7540 of 23,476 trials

Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin

NCT02609503

This study is being done to evaluate the efficacy of Pembrolizumab, concomitant with and following standard of care definitive radiation, for locally advanced squamous cell carcinoma of the head and neck patients who are not good candidates for Cisplatin.

Head and Neck Cancer

UNC Lineberger Comprehensive Cancer Center29 participantsStarted May 2016

Baltimore, Maryland, United States • Chapel Hill, North Carolina, United States • Philadelphia, Pennsylvania, United States

TERMINATEDPhase 4< 1 mile

Induction Optimization With Stelara for Crohn's Disease

NCT04629196

This is a 16-week randomized controlled trial comparing a second IV weight-based induction dose at week 8 to standard 90mg subcutaneous dose at week 8, with a primary endpoint of clinical remission at week 16.

Crohn Disease

NYU Langone Health12 participantsStarted Feb 2022

Baltimore, Maryland, United States • New York, New York, United States

UNKNOWN< 1 mile

Multidisciplinary Approach to Reduce Cardiovascular Health Disparities

NCT06168968

The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke. Participants will engage in laboratory testing and health outcome assessments.

Acute Coronary SyndromeMulti Vessel Coronary Artery DiseaseIschemic Stroke

LifeBridge Health400 participantsStarted Feb 2023

Baltimore, Maryland, United States

Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin

Induction Optimization With Stelara for Crohn's Disease

Multidisciplinary Approach to Reduce Cardiovascular Health Disparities

Find Trials by Condition in Baltimore

A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

Memory Retrieval and Encoding Investigated by Neural Stimulation

Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

A Study of ASP1951 in Subjects With Advanced Solid Tumors

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)

Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

Preemie Hypothermia for Neonatal Encephalopathy

A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug

A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility

Vaginal Photobiomodulation for Chronic Pelvic Pain

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.